ProText Mobility, Inc. (OTCPK: TXTM)
Health Care · Biotechnology · US
$0.00
-6.41% today · +10.6% 1Y
ProText Mobility, Inc. (OTCPK: TXTM) operates in the Biotechnology industry within the Health Care sector. The company is valued at $32.09M and employs 30 people.
Over the last twelve months the share price has gained 10.6%, trading between 0.00 and 0.01.
TXTM price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $32.09M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- —
- Dividend yield
- —
- Beta (5Y)
- -2.81
- 52-week high
- $0.01
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 8.79B
- Employees
- 30
- Next earnings
- —
About ProText Mobility, Inc.
ProText Mobility, Inc., a biotech company, engages in the development of pharmaceutical botanical medicines. Its medicines are formulated with highly-bioavailable plant extracts. The company is based in Fort Lauderdale, Florida.
- ISIN
- US74371E2046
- Listed since
- Aug 19, 2003
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $469.68B | $265.79 | +0.48% |
| Amgen Inc.NasdaqGS: AMGN | $239.09B | $442.24 | -0.36% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $184.47B | $148.77 | +1.38% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $140.13B | $552.85 | +0.96% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.24B | $833.56 | +0.61% |
| argenx SEENXTBR: ARGX | $64.17B | €879.20 | +1.74% |
| Moderna, Inc.NasdaqGS: MRNA | $63.41B | $158.83 | +14.36% |
| CSL LimitedASX: CSL | $59.49B | AU$173.64 | +2.68% |
Figures last refreshed Aug 18, 2026.